Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Sickle Cell 101 Unveils Its Innovative Approach in Digital Advocacy for a 'Rare' Disorder Through Social Media
Today 12:55 EST
Via
Newsfile
Exposures
Product Safety
Jay Vics Interviews Ezralea Robbins of Mountainside Spa in Episode 44 of Meet the Experts Podcast
Today 12:06 EST
Via
Press Advantage
Topics
Product Recall
Exposures
Legal
Product Safety
Clarius Announces the First FDA-Cleared AI Ultrasound Application for Musculoskeletal Imaging
Today 6:00 EST
Via
Newswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
420 with CNW — FDA Publishes Final Guidance for Cannabis Drug Development
Today 4:25 EST
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
Product Safety
Tickers
IGC
420 with CNW — FDA Publishes Final Guidance for Cannabis Drug Development
Today 4:25 EST
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
Product Safety
Tickers
IGC
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures ~$8.4M in Registered Direct Offering and Concurrent Private Placement
January 31, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
NMRD
The Car Law Firm provides its service to deceived clients in automobile purchasing.
January 31, 2023
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
AgelessRx Announces the Availability of Acarbose to Block Starchy Carbs and Improve Weight Loss with Dieting and Medication
January 31, 2023
Via
GetFeatured
Exposures
Ethanol
Product Safety
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
January 31, 2023
Via
NewMediaWire
Exposures
Product Safety
Tickers
UEEC
Lexaria Bioscience: Charting a Path to Commercial Success
January 31, 2023
Via
NewMediaWire
Exposures
Product Safety
Tickers
LEXX
Overnight Glasses Introduces A New Page Where They Gathered Every Information, Resource, And Online Feature One Might Need When Buying Eyeglasses Online
January 31, 2023
Via
Magic PR
Exposures
Product Safety
Glint Pharmaceuticals Receives FDA IND Acceptance for Clinical Study for Phase 1/2 Clinical Trial of Antibiotic Drug-Releasing Contact Lens, ACL5
January 31, 2023
Via
24-7 Press Release
Exposures
Product Safety
ZetrOZ Systems to Attend and Present at the Big Sky Athletic Training Sports Medicine Conference
January 30, 2023
Via
Newswire.com
Exposures
Product Safety
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Commences Recruitment in FSD201 Phase 2 Clinical Trial
January 30, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
CSE:HUGE
HUGE
Immediate Therapy for Urinary Incontinence in Women
January 30, 2023
Via
PRLog
Exposures
Product Safety
Cassava Sciences Stock Undervalued with Its $124 Price Target?
January 30, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
AZN
BIIB
LLY
MRK
TOP RANKED ROSEN LAW FIRM Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
January 29, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
YMAB
Dell Laser Consultants Announces Treatment of First Patient in Austin With the IC-8® Apthera™ IOL
January 27, 2023
Via
Newswire.com
Exposures
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
January 27, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
NMRD
Ainnova Tech announces Dr. Maziar Lalezary, M.D. as Medical advisor and member of Medical Board
January 27, 2023
Via
Zexprwire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
January 27, 2023
Via
Newsfile
Exposures
Product Safety
Tickers
SKYE
cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News
January 26, 2023
Via
Newsfile
Exposures
Product Safety
Tickers
YCBD
YMAB NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
January 26, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
YMAB
Report on 63 FDA-Approved Brand Names Released by Branding Agency, Brandsymbol
January 26, 2023
Via
Press Advantage
Exposures
Product Safety
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
January 26, 2023
Via
FinancialNewsMedia
Exposures
Product Safety
Tickers
CSE:LOBE
LOBEF
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
AZN
BNTX
CVS
GILD
How Could GSK's RSV Vaccine Change its Valuation?
January 26, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
GSK
MRNA
PFE
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Advances Novel Drug Candidate in Treating Alzheimer’s Symptoms
January 25, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
IGC
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
January 25, 2023
Via
MarketBeat
Topics
Workforce
Exposures
Layoff
Product Safety
Tickers
EDIT
ELEV
FATE
IPSC
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Doses First Participants in PH10 Phase 1 Clinical Trial
January 24, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
VTGN
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.